Federated Hermes
SGMT icon

Federated Hermes’s Sagimet Biosciences SGMT Stock Holding History

Federated Hermes’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
2,086,715
+2,085,934
+267,085% +$14.2M 0.02% 550
2026
Q1 		$4.08K Buy
781
+519
+198% +$2.89K ﹤0.01% 1913
2025
Q4 		$1.55K Sell
262
-301
-53% -$2.16K ﹤0.01% 1987
2025
Q3 		$3.86K Buy
+563
New +$4.57K ﹤0.01% 1966
2024
Q4 		– Sell
-60,000
Closed -$166K – 2177
2024
Q3 		$166K Sell
60,000
-8,000
-12% -$24.7K ﹤0.01% 1511
2024
Q2 		$233K Buy
68,000
+14,000
+26% +$64.2K ﹤0.01% 1451
2024
Q1 		$293K Sell
54,000
-43,276
-44% -$311K ﹤0.01% 1430
2023
Q4 		$527K Buy
97,276
+19,276
+25% +$90.9K ﹤0.01% 1330
2023
Q3 		$686K Buy
+78,000
New +$1.04M ﹤0.01% 1249

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes's SGMT Position: Q2 2026 in Review

Federated Hermes increased its Sagimet Biosciences (SGMT) stake by 267,085% in Q2 2026, buying an estimated $14.2M and bringing the position to 2,086,715 shares worth $16.1M. The position accounts for 0.02% of the portfolio, ranked #550.

Federated Hermes first reported a position in SGMT in Q3 2023 and has held it in 9 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Federated Hermes held 2,086,715 shares of Sagimet Biosciences worth $16.1M as of Q2 2026.
  • Federated Hermes bought 2,085,934 Sagimet Biosciences shares in Q2 2026, an estimated $14.2M.
  • Sagimet Biosciences made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #550 holding.
  • Federated Hermes first reported a position in Sagimet Biosciences in Q3 2023 and has held it in 9 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.